AI assistant
Bolt Biotherapeutics, Inc. — Director's Dealing 2025
Dec 16, 2025
35210_dirs_2025-12-16_ab740392-0a67-45ec-a004-749d67041d13.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Bolt Biotherapeutics, Inc. (BOLT)
CIK: 0001641281
Period of Report: 2025-12-12
Reporting Person: Nemec Sarah (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 1236 | Acquired | 2030-09-02 | Common Stock (1236) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $86.80 | D | 1236 | Disposed | 2030-09-02 | Common Stock (1236) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 375 | Acquired | 2031-02-03 | Common Stock (375) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $400.00 | D | 375 | Disposed | 2031-02-03 | Common Stock (375) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 600 | Acquired | 2031-12-21 | Common Stock (600) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $90.20 | D | 600 | Disposed | 2031-12-21 | Common Stock (600) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 2199 | Acquired | 2032-02-17 | Common Stock (2199) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $61.60 | D | 2199 | Disposed | 2032-02-17 | Common Stock (2199) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 6699 | Acquired | 2033-01-18 | Common Stock (6699) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $27.80 | D | 6699 | Disposed | 2033-01-18 | Common Stock (6699) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 1589 | Acquired | 2034-03-03 | Common Stock (1589) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $25.40 | D | 1589 | Disposed | 2034-03-03 | Common Stock (1589) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 2499 | Acquired | 2034-07-22 | Common Stock (2499) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $14.602 | D | 2499 | Disposed | 2034-07-22 | Common Stock (2499) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 4499 | Acquired | 2034-07-22 | Common Stock (4499) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $14.602 | D | 4499 | Disposed | 2034-07-22 | Common Stock (4499) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $5.44 | A | 11299 | Acquired | 2035-04-30 | Common Stock (11299) | Direct |
| 2025-12-12 | Employee Stock Option (Right to Buy) | $7.02 | D | 11299 | Disposed | 2035-04-30 | Common Stock (11299) | Direct |
Footnotes
F1: The option is fully vested and exercisable.
F2: The reporting person agreed to cancellation of an option granted on September 3, 2020, in exchange for a new option having a lower exercise price.
F3: The reporting person agreed to cancellation of an option granted on February 4, 2021, in exchange for a new option having a lower exercise price.
F4: The reporting person agreed to cancellation of an option granted on December 22, 2021, in exchange for a new option having a lower exercise price.
F5: The reporting person agreed to cancellation of an option granted on February 18, 2022, in exchange for a new option having a lower exercise price.
F6: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2023.
F7: The reporting person agreed to cancellation of an option granted on January 19, 2023, in exchange for a new option having a lower exercise price.
F8: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2024.
F9: The reporting person agreed to cancellation of an option granted on March 4, 2024, in exchange for a new option having a lower exercise price.
F10: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.
F11: The reporting person agreed to cancellation of an option granted on July 23, 2024, in exchange for a new option having a lower exercise price.
F12: For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2025.
F13: The reporting person agreed to cancellation of an option granted on May 1, 2025, in exchange for a new option having a lower exercise price.